Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,389 | -6,512 | -2,943 | -12,890 | -10,629 |
| Other Working Capital | 1,121 | 227 | -289 | 1,494 | 485 |
| Other Operating Activity | 1,225 | 666 | 156 | 1,892 | 1,707 |
| Operating Cash Flow | $-10,043 | $-5,619 | $-3,076 | $-9,504 | $-8,437 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,879 | 16,000 | 16,000 | N/A | 0 |
| Other Financing Activity | -3,938 | -2,551 | -1,973 | 15,246 | 15,246 |
| Financing Cash Flow | $27,941 | $13,449 | $14,027 | $15,246 | $15,246 |
| Beginning Cash Position | 5,742 | 5,742 | 5,742 | 0 | N/A |
| End Cash Position | 23,640 | 13,572 | 16,693 | 5,742 | 6,809 |
| Net Cash Flow | $17,898 | $7,830 | $10,951 | $5,742 | $6,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,043 | -5,619 | -3,076 | -9,504 | -8,437 |
| Free Cash Flow | -10,043 | -5,619 | -3,076 | -9,504 | -8,437 |